MassMutual Private Wealth & Trust’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-215	Closed	-$4K	–	1515
2021 Q3	$4K	Hold	215	–	–	﹤0.01%	959
2021 Q2	$8K	Buy	+215	New	+$6.59K	﹤0.01%	743

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

MassMutual Private Wealth & Trust's DRNA Position: Q4 2021 in Review

MassMutual Private Wealth & Trust sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 215 shares — an estimated $4K sold.

MassMutual Private Wealth & Trust first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $8K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

MassMutual Private Wealth & Trust reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 215 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $4K.
MassMutual Private Wealth & Trust first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
MassMutual Private Wealth & Trust's Dicerna Pharmaceuticals, Inc. position peaked at $8K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2021, filed 9 Feb 2022.